Real‐world data prognostic model of overall survival in patients with advanced NSCLC receiving anti‐PD‐1/PD‐L1 immune checkpoint inhibitors as second‐line monotherapy by Cristina Julian, Robson J. M. Machado, Sandhya Girish, Pascal Chanu, Dominik Heinzmann, Chris Harbron, Anda Gershon, Shannon M. Pfeiffer, Wei Zou, Valerie Quarmby, Qing Zhang, Yachi Chen

Get full text